Shanmuga Hospital empanelled under CGHS for 3 years

Business Updates View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.0%Reaction day

₹36.25

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.7%+1.7% vs market

Hospital peers, median of 24sector-0.8%+1.9% vs sector

On the reaction day the stock moved 1.7 pts more than Nifty Microcap 250 and 1.9 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.0-0.7+1.7-0.8+1.9

Next day

+4.8-2.7+7.5-2.4+7.3

+6.3-0.8+7.1-0.5+6.8

+29.7+0.5+29.1-0.4+30.1

+26.8+0.7+26.2-0.2+27.0

+32.4-0.3+32.8-1.2+33.6

+29.8-0.2+29.9-0.0+29.8

15d

—-1.7—-1.1—

+28.3+2.7+25.6+0.9+27.4

—+4.8—-0.6—

+18.6+3.2+15.4-10.7+29.3

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 24Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Shanmuga Hospital has been empanelled under the Central Government Health Scheme (CGHS), Ministry of Health and Family Welfare, for a period of 3 years with effect from 19 June 2026. Under the agreement, the hospital will provide healthcare services to Central Government employees, pensioners and other eligible CGHS beneficiaries as per the agreed terms. The company expects this to broaden its patient base, improve accessibility of its services and strengthen its position as a government-empanelled healthcare provider.

Likely market impact

Positive — grants access to a large pool of government-employee and pensioner patients, supporting patient volumes and revenue diversification over the 3-year tenure.